Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non–small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)
Beau-Faller, Michèle, Texier, Matthieu, Blons, Hélène, Richard, Nicolas, Escande, Fabienne, Melaabi, Samia, Lizard, Sarab, De Fraipont, Florence, Longchampt, Elisabeth, Morin, Franck, Zalcman, Gérard,Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2018.12.012
Date:
December, 2018
File:
PDF, 681 KB
2018
File converter
More search results
More benefits 
